| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:14:55 UTC |
|---|
| Update date | 2025-11-19 02:29:16 UTC |
|---|
| Primary ID | FDB020276 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | Trachelogenin |
|---|
| Description | Trachelogenin is a member of the class of compounds known as dibenzylbutyrolactone lignans. Dibenzylbutyrolactone lignans are lignan compounds containing a 3,4-dibenzyloxolan-2-one moiety. Trachelogenin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Trachelogenin can be found in burdock and grape wine, which makes trachelogenin a potential biomarker for the consumption of these food products. |
|---|
| CAS Number | 34209-69-3 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| (-)-Trachelogenin | biospider | | 2(3H)-Furanone, dihydro-3-hydroxy-3-vanillyl-4-veratryl- | biospider | | Trachelogenin | db_source |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C21H24O7 |
|---|
| IUPAC name | 4-[(3,4-dimethoxyphenyl)methyl]-3-hydroxy-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one |
|---|
| InChI Identifier | InChI=1S/C21H24O7/c1-25-17-7-5-13(9-19(17)27-3)8-15-12-28-20(23)21(15,24)11-14-4-6-16(22)18(10-14)26-2/h4-7,9-10,15,22,24H,8,11-12H2,1-3H3 |
|---|
| InChI Key | YFVZKLQNMNKWSB-UHFFFAOYSA-N |
|---|
| Isomeric SMILES | COC1=CC(CC2(O)C(CC3=CC(OC)=C(OC)C=C3)COC2=O)=CC=C1O |
|---|
| Average Molecular Weight | 388.4111 |
|---|
| Monoisotopic Molecular Weight | 388.152203122 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as dibenzylbutyrolactone lignans. These are lignan compounds containing a 3,4-dibenzyloxolan-2-one moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lignans, neolignans and related compounds |
|---|
| Class | Furanoid lignans |
|---|
| Sub Class | Tetrahydrofuran lignans |
|---|
| Direct Parent | Dibenzylbutyrolactone lignans |
|---|
| Alternative Parents | |
|---|
| Substituents | - Dibenzylbutyrolactone
- Lignan lactone
- Methoxyphenol
- O-dimethoxybenzene
- Dimethoxybenzene
- Phenoxy compound
- Anisole
- Methoxybenzene
- Phenol ether
- 1-hydroxy-2-unsubstituted benzenoid
- Alkyl aryl ether
- Phenol
- Monocyclic benzene moiety
- Gamma butyrolactone
- Benzenoid
- Tetrahydrofuran
- Tertiary alcohol
- Carboxylic acid ester
- Lactone
- Organoheterocyclic compound
- Ether
- Oxacycle
- Carboxylic acid derivative
- Monocarboxylic acid or derivatives
- Organic oxygen compound
- Alcohol
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Ontology | No ontology term |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Not Available | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 64.94%; H 6.23%; O 28.83% | DFC |
|---|
| Melting Point | Mp 139-141° | DFC |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | Not Available | |
|---|
| Experimental logP | Not Available | |
|---|
| Experimental pKa | Not Available | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | [a]23D -43.5 (c, 0.25 in EtOH) | DFC |
|---|
| Spectroscopic UV Data | 280 (e 4700) (MeOH) (Berdy) | DFC |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | Not Available |
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-000i-0519000000-1014d5320482c475be95 | 2019-02-22 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-000i-0924000000-d6eced9520b64982b597 | 2019-02-22 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-052r-2901000000-da8c42bb7e0b206e92d9 | 2019-02-22 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-000i-0069000000-66299dd4a05ea7d2b694 | 2019-02-23 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-000i-0449000000-5f524d23f8e4a3e9c3f4 | 2019-02-23 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-02g7-0659000000-956f0981807b4de1534b | 2019-02-23 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-000i-0019000000-86491115644010258ccd | 2021-10-21 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-000i-0933000000-7e11a408dd9a1b1a3d83 | 2021-10-21 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0079-3958000000-00e44846a35cf59c83be | 2021-10-21 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-000i-0009000000-2c73c7ca58264e177ca3 | 2021-10-21 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-000i-0933000000-ab4cca7d5a9a4a636257 | 2021-10-21 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-000l-4923000000-d4a6151a3c862b2d9e10 | 2021-10-21 | View Spectrum |
|
|---|
| NMR | Not Available |
|---|
| External Links |
|---|
| ChemSpider ID | 437574 |
|---|
| ChEMBL ID | Not Available |
|---|
| KEGG Compound ID | C10891 |
|---|
| Pubchem Compound ID | 452855 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | Not Available |
|---|
| Phenol-Explorer ID | 601 |
|---|
| DrugBank ID | Not Available |
|---|
| HMDB ID | Not Available |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | MBB20-R:MNC00-W |
|---|
| EAFUS ID | Not Available |
|---|
| Dr. Duke ID | TRACHELOGENIN |
|---|
| BIGG ID | Not Available |
|---|
| KNApSAcK ID | C00000600 |
|---|
| HET ID | Not Available |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Not Available |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Anti HIV | 22587 | An agent that prevents the replication of the Human Immunodeficiency Virus (HIV), used to treat and manage HIV infection and Acquired Immunodeficiency Syndrome (AIDS), reducing viral load and slowing disease progression. | DUKE | | Anti hypertensive | 52217 | An agent that lowers blood pressure, reducing the risk of cardiovascular disease. It plays a biological role in relaxing blood vessels, decreasing cardiac workload, and improving blood flow. Therapeutically, it's used to manage hypertension, heart failure, and stroke, with key medical applications in preventing organ damage and improving overall cardiovascular health. | DUKE | | Anti-integrase | 23924 | An agent that blocks the activity of integrase, an enzyme essential for HIV replication, reducing viral integration into host DNA. Therapeutically, it's used to treat HIV infection, preventing the virus from replicating and slowing disease progression, commonly used in combination with other antiretroviral therapies. | DUKE | | Anti leukemic | 35610 | An agent that targets and inhibits the growth of leukemia cells, playing a crucial role in cancer treatment. Therapeutically, it is used to induce remission, manage symptoms, and improve survival rates in patients with leukemia. Key medical uses include treating acute and chronic leukemia, lymphoma, and other hematological malignancies. | DUKE | | Anti-lymphomic | | An agent that targets and destroys lymphatic cells that form tumors, playing a crucial role in cancer treatment. Therapeutically, it is used to manage lymphomas, with key medical applications in chemotherapy and immunotherapy to combat blood cell cancers. | DUKE | | Anti topoisomerase-II | 50750 | An agent that inhibits topoisomerase-II, an enzyme involved in DNA replication. Therapeutically, it's used in cancer treatment, particularly in leukemia and lymphoma, to prevent DNA replication and induce cell death. Key medical uses include chemotherapy for various cancers, exploiting its ability to disrupt DNA processes and halt tumor growth. | DUKE | | Calcium antagonist | 48706 | A medication that blocks calcium ion entry into cells, reducing muscle contraction and vascular resistance. It treats hypertension, angina, and arrhythmias by dilating blood vessels and decreasing cardiac workload, commonly used in managing cardiovascular diseases. | DUKE | | Cardiac | 38070 | Relating to the heart, referring to agents or functions that support heart health, treat cardiovascular diseases, or regulate heart rhythm, commonly used in managing conditions such as arrhythmias, heart failure, and hypertension. | DUKE | | Cytostatic | | An agent that inhibits cell growth, playing a biological role in regulating cell proliferation. Therapeutically, it is used to slow or stop the growth of abnormal cells. Key medical uses include cancer treatment, where it helps prevent tumor growth, and in managing conditions like psoriasis and rheumatoid arthritis. | DUKE | | HIV-reverse-transcriptase inhibitor | 23924 | An agent that blocks the activity of reverse transcriptase, an enzyme essential for HIV replication, reducing viral load and slowing disease progression. Therapeutically, it is used to treat HIV/AIDS, often in combination with other antiretroviral medications to prevent drug resistance and manage symptoms. | DUKE | | Pesticide | 25944 | An agent that kills or repels pests, playing a biological role in controlling insect, weed, and fungal populations. Therapeutically, pesticides have limited applications, but some are used to treat ectoparasitic infestations, such as lice and scabies. Key medical uses include topical treatments for head lice and scabies, highlighting their role in managing parasitic infections. | DUKE | | Topoisomerase inhibitor | 23924 | An agent that blocks the activity of topoisomerase enzymes, which unwind DNA during replication. Therapeutically, it prevents cancer cell growth, commonly used in managing various types of cancer, including leukemia, lymphoma, and solid tumors. | DUKE |
|
|---|
| Enzymes | Not Available |
|---|
| Pathways | Not Available |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | Not Available |
|---|
| Files |
|---|
| MSDS | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004). — Rothwell JA, Pérez-Jiménez J, Neveu V, Medina-Ramon A, M'Hiri N, Garcia Lobato P, Manach C, Knox K, Eisner R, Wishart D, Scalbert A. (2013) Phenol-Explorer 3.0: a major update of the Phenol-Explorer database to incorporate data on the effects of food processing on polyphenol content. Database, 10.1093/database/bat070.
|
|---|